Regeneron Pharmaceuticals, Inc. (FRA:RGO)
Germany
· Delayed Price · Currency is EUR 616.20
+4.00 (0.65%)
Last updated: Dec 5, 2025, 8:10 AM CET
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €63.36 billion as of December 5, 2025. Its market cap has decreased by -16.26% in one year.
Market Cap
63.36B
Enterprise Value
49.58B
Revenue
12.14B
Ranking
n/a
PE Ratio
16.24
Stock Price
€616.20
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 63.36B, an increase of 48,111.72%. That is a compound annual growth rate of 20.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 244.74B |
| Siemens Aktiengesellschaft | 178.22B |
| Allianz SE | 139.47B |
| Deutsche Telekom AG | 130.38B |
| Siemens Energy AG | 99.77B |
| Rheinmetall AG | 70.66B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.64B |
| Deutsche Bank Aktiengesellschaft | 59.08B |